AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Kaiser Permanente research: Vaccine cuts infection risk in half.(Staphylococcus aureus infections)(Brief Article)

Vaccine Weekly

| March 27, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

1902 MAR 27 - (NewsRx.com & NewsRx.net) -- In a study led by Kaiser Permanente researchers Henry Shinefield, MD, and Steven Black, MD, published in the February 14, 2002 issue of the New England Journal of Medicine, an investigational vaccine showed 57% effectiveness against Staphylococcus aureus infections in dialysis patients.

"That's a significant response," said lead author Shinefield. "Staph is a major cause of infections, and dialysis patients are particularly at risk because of their already weakened immune systems."

Staph can cause serious illness and death among its victims. Bacteremia, one of the illnesses attributed to the S. aureus bacteria, is a particularly prominent cause of ...

Related articles from newspapers, magazines, journals, and more
Nabi Biopharmaceuticals Receives FDA Orphan Drug Designation for Altastaph(TM);...
Press release article from: PR Newswire February 11, 2004 700+ words
...immediate protection against Staph aureus infections in low birth-weight infants. The...and regulatory affairs. "Staph aureus infections represent a significant cause of...for approximately 85% of all Staph aureus infections. These antibodies are the same antibodies...
Nabi Biopharmaceuticals Launches New Study to Evaluate StaphVAX(R)'s Ability to...
Press release article from: PR Newswire September 20, 2005 700+ words
...are at high chronic risk for S. aureus infections. The trial will evaluate StaphVAX...aureus infection this year. -- S. aureus infections keep patients in the hospital longer...for a methicillin-resistant S. aureus infections suffer a recurrence in a short amount...
Nabi Biopharmaceuticals Files for European Regulatory Approval for StaphVAX(R)...
Newspaper article from: PR Newswire Europe December 21, 2004 700+ words
...commercial presence in Europe. Staph aureus infections represent one of the EU's most...We believe that preventing Staph aureus infections before they harm patients may become...adult patient populations. About S. aureus infections in Europe and worldwide The issues...
Inhibitex Completes Phase I Study of Aurexis(R); Investigational Drug to Treat...
Press release article from: PR Newswire September 8, 2003 700+ words
...serious Staphylococcus aureus (S. aureus) infections in hospitalized patients. The Phase...million healthcare-associated S. aureus infections each year, 25-30% of which are...current antibiotic therapies, S. aureus infections, particularly those in the blood...
Inhibitex to Initiate Phase I/II Clinical Trial for Product to Prevent...
Press release article from: Business Wire October 28, 1999 700+ words
...in the hemodialysis patients. S. aureus infections represent the second leading cause...developed to reduce the incidence of S. aureus infections in patients who are undergoing hemodialysis...elevated risk for developing S. aureus infections. Dr. Joseph Patti, Vice President...
4SC and Academic Research Consortium Receives EU Grant to Develop New Drugs To...
Press release article from: PR Newswire December 16, 2002 700+ words
...drugs to combat Staphylococcus aureus infections with a grant of EURO 2.2 million. Staphylococcus aureus infections are becoming a serious public...problem." About Staphylococcus aureus Infections Staphylococcus aureus can be...
Inhibitex Commences Phase I/II Clinical Testing of Lead Product to Treat...
Press release article from: Business Wire March 22, 2000 700+ words
...treat Staphylococcus aureus (S. aureus) infections. The lead product is S. aureus...scientific forum. "Staphylococcus aureus infections are the second leading cause of death...hemodialysis exceeds $10 billion. S. aureus infections contribute significantly to these...
Staphylococcus aureus infections.(Brief Article)(Book Review)
Magazine article from: SciTech Book News December 1, 2005 700+ words
0791085082 Staphylococcus aureus infections. Freeman-Cook, Lisa and Kevin Freeman-Cook. Chelsea...Beginning with some gruesome stories about staphylococcus aureus infections, this text for high school students goes on to prove that...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA